CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for JW Life Science Corp (Parent) is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

JW Life Science Corp (Parent)
28, Hanjin 1-gil, Songak-eup
Phone: +82 413517600p:+82 413517600 DANGJIN, 31720  South Korea Fax: +82 413517655f:+82 413517655

This is a Subsidiary, click here for the Parent Company

Business Summary
JW Life Science Co. Ltd. is a Korea-based company primarily engaged in manufacture and distribution of Intravenous (IV) fluid products and infusion solutions. The Company is engaged in manufacture of basic IV fluid including water, electrolytes and glucose; nutrient infusion solution including amino acids, lipids, proteins, vitamins and minerals; and special infusion solution, which is used in special cases. The Company is also engaged in manufacture of total parenteral nutrition (TPN) products and others.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/201612/31/2015Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman & CEO Jong HoLee 89
Vice Chairman & Chief Executive Officer Gyeong HaLee 58
Chief Executive Officer Gu SeoPark 60
5 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 15,834,554 (As of 6/30/2020)
Fax Number: +82 413517655


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, August 29, 2023